BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1648338)

  • 1. Purification and characterization of human fibroblast derived differentiation inducing factor for human monoblastic leukemia cells identical to interleukin-6.
    Noda M; Takeda K; Sugimoto H; Hosoi T; Takechi K; Hara T; Ishikawa H; Arimura H; Konno K
    Anticancer Res; 1991; 11(2):961-8. PubMed ID: 1648338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a low molecular weight factor that induces differentiation and inhibits growth in myeloid leukemia cells.
    Nakaya K; Kumakawa N; Iinuma H; Nakamura Y
    Cancer Res; 1988 Aug; 48(15):4201-5. PubMed ID: 3164645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5).
    McKenzie DT; Filutowicz HI; Swain SL; Dutton RW
    J Immunol; 1987 Oct; 139(8):2661-8. PubMed ID: 3498767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion.
    Ohnishi T; Arita N; Hayakawa T; Kawahara K; Kato K; Kakinuma A
    Biochem Biophys Res Commun; 1993 Jun; 193(2):518-25. PubMed ID: 8390244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor.
    Tagaya Y; Okada M; Sugie K; Kasahara T; Kondo N; Hamuro J; Matsushima K; Dinarello CA; Yodoi J
    J Immunol; 1988 Apr; 140(8):2614-20. PubMed ID: 2895791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive production of interleukin 1 by human monocytic leukemia cell line JOSK-I and the production mechanism.
    Furukawa Y; Ohta M; Kasahara T; Miura Y; Saito M
    Cancer Res; 1987 May; 47(10):2589-93. PubMed ID: 3494502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and partial characterization of a thrombin-like/gyroxin enzyme from bushmaster (Lachesis muta rhombeata) venom.
    Aguiar AS; Alves CR; Melgarejo A; Giovanni-de-Simone S
    Toxicon; 1996 May; 34(5):555-65. PubMed ID: 8783450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an eosinophilic leukemia cell differentiation factor (ELDF) produced by a human T cell leukemia cell line, HIL-3.
    Ohshima Y; Morita M; Hirashima M; Mori KJ; Akutagawa H; Katamura K; Mayumi M; Mikawa H
    Exp Hematol; 1993 Jun; 21(6):749-54. PubMed ID: 8500576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line.
    Rimsky L; Wakasugi H; Ferrara P; Robin P; Capdevielle J; Tursz T; Fradelizi D; Bertoglio J
    J Immunol; 1986 May; 136(9):3304-10. PubMed ID: 3485686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line.
    Watson JD; Crosier PS; March CJ; Conlon PJ; Mochizuki DY; Gillis S; Urdal DL
    J Immunol; 1986 Aug; 137(3):854-7. PubMed ID: 3088112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
    Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
    Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification and initial characterization of a novel differentiation factor for mouse myeloid leukemia cells.
    Nakaya K; Kumakawa N; Nakamura Y
    Biochem Int; 1985 Apr; 10(4):619-26. PubMed ID: 3861183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
    Cavanaugh PG; Nicolson GL
    Cancer Res; 1989 Jul; 49(14):3928-33. PubMed ID: 2544264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.
    Nordan RP; Pumphrey JG; Rudikoff S
    J Immunol; 1987 Aug; 139(3):813-7. PubMed ID: 3496392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes.
    Yoshimura T; Robinson EA; Tanaka S; Appella E; Leonard EJ
    J Immunol; 1989 Mar; 142(6):1956-62. PubMed ID: 2921521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
    Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
    J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Purification and partial biochemical characterization of the rabbit interleukin-1].
    Perumov ND; Simbirtsev AS; Mitrofanov EV; Shishov AK; Ketlinskiĭ SA
    Biokhimiia; 1988 Jan; 53(1):25-30. PubMed ID: 3258760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.